Current Treatment Options in Neurology

Papers
(The median citation count of Current Treatment Options in Neurology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Tau in Multiple Sclerosis: A Review of Therapeutic Potential91
Role of Gut Microbiome in Depression36
Epilepsy as a Wilding of Sleep34
Race/Ethnicity Considerations in the Prevention and Treatment of Stroke26
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome21
Postoperative Neurosurgical Complications in Neurocritical Care21
The Effect of Obstructive Sleep Apnea on Cognition: A Focus on Decision-Making17
Clinical Applications of Non-Invasive Brain Stimulation in Stroke Recovery: A Review of Current Evidence and Therapeutic Strategies16
Delving Into the Significance of Brain’s Collateral Circulation in the Era of Revascularization Therapy11
Genetic Testing for Epilepsy: A User Guide11
Mechanical Thrombectomy for Acute Ischemic Stroke: Current State and Future Directions10
Education and Team Science in Neurocritical Care9
Practical Approaches to the Treatment of Neonatal Seizures9
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations9
MOG-IgG Associated Disease (MOG-AD) in Adults8
Dual Antiplatelet Therapy in Ischemic Stroke Prevention: Which Two Could Be Better than One?8
Ultrasound-Guided Therapies in the Neuro ICU8
Accessing Investigational Products Outside of a Trial: Considerations for Neuromuscular Providers6
Advanced Imaging in the Era of Tissue-Based Treatment for Acute Ischemic Stroke—a Practical Review5
Update on the Diagnostic and Therapeutic Landscape of Sporadic Inclusion Body Myositis4
Temperature Control in Hypoxic-Ischemic Brain Injury—a Focused Update4
Current Treatment Options for Patients with Myotonic Dystrophy Type 24
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis4
A Review of Adult-Onset Hearing Loss: a Primer for Neurologists4
Brain-Lung Crosstalk: Management of Concomitant Severe Acute Brain Injury and Acute Respiratory Distress Syndrome3
Correction to: Diagnosis and Management of Posterior Cortical Atrophy3
Rescue Medications for Acute Repetitive Seizures3
Update on Paraneoplastic Neuromuscular Disorders3
Fenfluramine for the Treatment of Dravet Syndrome and Lennox Gastaut Syndrome: A Review3
The Impact of Epstein-Barr Virus on Autoimmune Neuromuscular Disorders: A Comparative Study of Myasthenia Gravis and Guillain–Barre Syndrome3
Evaluation and Management of Delirium in Dementia3
Article Topic: Neuropathies Due to Infections and Antimicrobial Treatments3
Shared Decision-Making and Family Meetings in Neurocritical Care3
Treatment of Obstructive Sleep Apnea in patients with Alzheimer’s Disease: role of Continuous Positive Airway Pressure therapy2
Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children2
Reducing Sudden Unexpected Death in Epilepsy: Considering Risk Factors, Pathophysiology and Strategies2
Progressive Supranuclear Palsy Diagnosis and Treatment2
Treatment of Vascular Myelopathies2
The Current Role of Valproic Acid in the Treatment of Epilepsy: A Glimpse into the Present of an Old Ally2
Self-care and Epilepsy2
Neurocritical Care of the Pregnant Patient2
Updated Review of Leber Hereditary Optic Neuropathy2
Updates in Fluid, Tissue, and Imaging Biomarkers for Dementia with Lewy Bodies and Implications for Biologically Based Disease Definitions2
A Review of the Current Literature and Updates on Embolic Stroke of Undetermined Source (ESUS)2
TINNITUS. A Non-invasive Neuromodulatory Perspective2
Update on Therapy for Myotonic Dystrophy Type 12
Treatment of Symptomatic Carotid Webs: Current Evidence and Future Directions2
Best Practices for Seizure Treatment in Oncology Patients2
Update on Simulation in Neurocritical Care – Current Applications and Future Directions2
Acute Stroke Treatment in an Anticoagulated Patient: When Is Thrombolysis an Option?2
Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas1
Treatment Approaches in Pediatric Relapsing Autoimmune Encephalitis1
Update on Treatment of Idiopathic (and Non-Idiopathic) Orbital Inflammation1
Vasculitic Neuropathies1
Diagnosis and Treatment of Inflammatory Cerebral Amyloid Angiopathy1
Management of External Ventricular Drains and Related Complications: a Narrative Review1
Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder1
Treatment Approaches for Functional Neurological Disorders in Children1
Update on Large-Vessel Revascularization in Acute Ischemic Stroke1
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy1
Speech Language Pathology in the Neurocritical Care Unit1
Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials1
Toxic Myopathies1
A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications1
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults1
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?1
Treatment of Epilepsy in the Setting of Cognitive Decline in Older Adults1
Diagnosis and Management of Posterior Cortical Atrophy1
Central Positional Nystagmus1
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease1
Seizure Management in the Intensive Care Unit1
Correction to: Diagnosis and Management of Progressive Corticobasal Syndrome1
Addressing the Burden of Pathological Fatigue in Stroke Survivors: A Review of Present and Potential Non-Pharmacological and Pharmacotherapeutic Options1
A New Era in the Treatment of Myasthenia Gravis: Six New Medications in The Last 6 Years1
Current Endovascular Treatments in Neuro-Ophthalmology0
Stroke Treatment in the Era of COVID-19: a Review0
Biomarker Defined Acute Optic Neuritis: A Review and Perspective0
Update on Toxic Neuropathies0
Treatment Updates for Neuropathy in Hereditary Transthyretin Amyloidosis0
Recommendations for Family Presence at the Bedside in Neurocritical Care0
Correction to: Clinical Practice Update Part I: Diagnosis and Treatment for Benign Paroxysmal Positional Vertigo0
Parkinson Disease Dementia Management: an Update of Current Evidence and Future Directions0
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview0
An Update on the Treatment of Basilar Artery Occlusion0
The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical Activity0
Update on Therapies for Mal de Débarquement Syndrome0
Management/Treatment of Lambert-Eaton Myasthenic Syndrome0
A Review of Calcitonin Gene-Related Peptide and Its Implications for Vestibular Disorders0
Clinical Trial Outcome Measurements in Lennox-Gastaut Syndrome and Their Application to the Development of Targeted Treatments0
Update on Transient Global Amnesia (TGA): Current Theories Underlying the Etiology, Diagnosis, Prognosis, and Management of TGA0
Correction to: Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas0
Update on ALS Treatment0
Treatment Strategies for Central Nervous System Effects in Primary and Secondary Haemophagocytic Lymphohistiocytosis in Children0
Clinical Management in Alzheimer’s Disease in the Era of Disease-Modifying Therapies0
Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications0
Mass Spectrometry-Based Approaches for Clinical Biomarker Discovery in Traumatic Brain Injury0
Headache as a Neurologic Manifestation of Systemic Disease0
Treatment of Downbeat Nystagmus and Cerebellar Ataxia0
Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?0
The Knowns and Unknowns of Prion Protein in Immune Modulation and the Pathogenesis of Neuroautoimmune Diseases0
Advances in the Pharmacological Management of Parkinson’s Disease0
The Need for Continuity of Care in Neurocritical Care and Recovery0
The A2F ICU Liberation Bundle in Neurocritical Care0
Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)0
Correction to: Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?0
Management Strategies for Atypical Parkinsonism0
Subependymal Giant Cell Astrocytomas (SEGAs): a Model of Targeting Tumor Growth and Epilepsy0
Update on Amyloid Polyneuropathy and Treatment0
Correction to: Gut Microbiome as Potential Therapeutics in Multiple Sclerosis0
Seizures in the Setting of COVID-190
Treatment of Intracerebral Vascular Malformations: When to Intervene0
Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?0
Correction to: Speech Language Pathology in the Neurocritical Care Unit0
The Role of Rehabilitation in Neurological Critical Care: Innovations in Early Mobilization0
Epilepsy Treatment in Patients with Heart Disease0
Distinguishing Benign Rashes From Severe Skin Reactions From Anti-Seizure Medications0
Update on Nodopathies of the Peripheral Nerve0
Early Mobilization in Neurocritical Care0
Managing the Behavioral and Psychological Symptoms of Dementia0
Treatment of Fever in Neurologically Critically Ill Patients0
Epstein-Barr Virus as a Therapeutic and Preventive Target in Multiple Sclerosis0
Optimizing Sleep and Circadian Health in the NeuroICU0
Quality Improvement in Neurocritical Care: a Review of the Current Landscape and Best Practices0
Neuromyelitis Optica Spectrum Disorders (NMOSD)0
The Role of Pharmacy in Neurocritical Care0
Treatment of Persistent Postural-Perceptual Dizziness (PPPD)0
Dementia Clinical Care in Relation to COVID-190
Multicolumn Spinal Cord Stimulation for Chronic Back and Leg Pain in Patients with Failed Back Surgery Syndrome: A Systematic Review and Meta-Analysis0
Sleep Disorders in Adults with Intellectual Disability: Current Status and Future Directions0
Update on the Treatment of Autonomic Disorders0
Telestroke’s Role Through the COVID-19 Pandemic and Beyond0
Diagnosis and Management of Progressive Corticobasal Syndrome0
Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review0
Clinical Practice Update Part I: Diagnosis and Treatment for Benign Paroxysmal Positional Vertigo0
Updates in the Management of Cervical Artery Dissections0
Neurocritical Care in Transplant Patients0
An Update on Palliative Care in Neurocritical Care: Providing Goal-Concordant Care in the Face of Prognostic Uncertainty0
Correction to: Ultrasound-Guided Therapies in the Neuro ICU0
Inhibiting CD40 Ligand in Multiple Sclerosis: A Review of Emerging Therapeutic Potential0
Current Management of Thyroid Eye Disease0
Treatment of Malignant Cerebral Edema in Acute Ischemic Stroke0
The Efficiency of Established Diagnostic and Therapeutic Approaches in the Treatment of Trigeminal Neuralgia0
Approach to the Management of Sodium Disorders in the Neuro Critical Care Unit0
Treatment and Prognosis After Hypoxic-Ischemic Injury0
Epilepsy Management in Transgender and Gender Diverse People0
Surgical Management of Spontaneous Intracerebral Hemorrhage0
Translating the ALS Genetic Revolution into Therapies: A Review0
Pharmacologic and Acute Management of Spinal Cord Injury in Adults and Children0
Predicting and Treating Post-traumatic Epilepsy0
Early Aggressive Treatment Approaches for Multiple Sclerosis0
The Efficacy of Deep Brain Stimulation in the Treatment of Essential Tremor: A Systematic Review0
Clinical Practice Update Part II: Considerations for Treatment and Management of Benign Paroxysmal Positional Vertigo0
Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)0
Ocular Myasthenia Gravis0
Current and Emerging Sleep Interventions for Older Adults with or without Mild Cognitive Impairment0
The Impacts of the Covid-19 Pandemic on Cerebral Infarction Treatment: Challenges and Opportunities0
Ethical Considerations in the Treatment of Cerebrovascular Disease0
0.13295006752014